Work

PS5-06-24: When Therapy Leaves a Mark: A Case of Ribociclib-Induced Vitiligo Reversed with Abemaciclib

Year: 2026

Type: article

Study design: Case Report

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-06-24

Authors: D. Urueta Portillo, S. Haddad, M. Mazo Canola

Institution: Mays Cancer Center at UT Health San Antonio

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129304803

FWCI:

Cites:

Cited by:

Related to: